NABL, CAP, ISO
Overview of Angiotensin Converting Enzyme
What is Angiotensin Converting Enzyme?
When you have granulomas that produce small bumps under the skin, a lingering cough, red watery eyes, and/or other symptoms suggestive of sarcoidosis; regularly when you have active sarcoidosis to monitor its course.
The sample type collected for Angiotensin Converting Enzyme is: Blood
Preparation for Angiotensin Converting Enzyme
- No special preparation required
Why Get Tested for Angiotensin Converting Enzyme?
- If you have signs or symptoms suggestive of sarcoidosis like chronic cough or shortness of breath, watery eyes, joint pains or grnaolaomas
- If you have been already diagnosed with sarcoidosis, this test may be ordered routinely to monitor the disease activity
What Results of Angiotensin Converting Enzyme mean?
- An increased ACE level in a person with clinical findings suggestive of sarcoidosis means that it is likely that a person has an active case of sarcoidosis, if other diseases have been ruled out. The finding of a high ACE level helps to confirm the diagnosis
- A normal ACE level cannot be sued to rule out sarcoidosis since sarcoidosis may be present without an elevated ACE level
- It may also be used to monitor the course of treatment in sarcoidosis. An initial high level which decreases over time usually indicates spontaneous or therapy induced remission and a favorable prognosis. On the other hand, a rising ACE level may indicate either the disease is not responding or it is progressing
Patient Concerns about Angiotensin Converting Enzyme
Frequently Asked Questions about Angiotensin Converting Enzyme
Q. Are there any other conditions except sarcoidosis which can lead to increased or decreased ACE levels?
Decreased ACE levels may also be seen in lung diseases like emphysema, hypothyroidism, starvation, steroid therapy. The levels may be moderately increased in hyperthyroidism, diabetes, alcoholic cirrhosis, lymphoma, tuberculosis, leprosy
We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic healthcare services and efficient service. With over 3368 diagnostic and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. Our key competitive strengths are: Business model focused on the patient as a customer and an established consumer healthcare brand associated with quality services, in a market where patients generally choose their diagnostic healthcare service provider. Well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry. A network whose growth yields greater economies of scale, combined with a hub and spoke model that is scalable for further growth. Centralized information technology platform that fully integrates our network and is scalable. Attractive financial performance, financial profile and return on invested capital. Experienced leadership team with strong industry expertise and successful track record. Some of our laboratories have achieved International Organization for Standardization, or ISO, certification for their quality systems. Our National Reference Laboratory has obtained ISO 9001:2008 certification (for the performance of routine and advanced diagnostic pathology testing services, including clinical trials), ISO 15189:2007 (for quality management in medical laboratories), ISO 15189:2012 certification (in the field of medical testing) and ISO 27001:2013 certification (for establishing an effective information management system that maintains and processes information security at our data center).